Home > Healthcare > Medical Devices > Diagnostic Devices > Cystatin C Assay Market
Cystatin C Assay Market Size
- Report ID: GMI7697
- Published Date: Dec 2023
- Report Format: PDF
Cystatin C Assay Market Size
Cystatin C Assay Market was valued at USD 269.6 million in 2023 and is anticipated to grow at a CAGR of over 7.7% between 2024 & 2032. A cystatin C assay is a laboratory test designed to measure the concentration of cystatin C in biological samples, typically in blood or serum. It is commonly used as a biomarker for estimating glomerular filtration rate (GFR). The assays play a vital role in the early diagnosis, monitoring, and kidney stone management, contributing to improved patient outcomes and driving innovation in the field of renal function assessment.
The increasing prevalence of chronic kidney diseases is anticipated to augment the cystatin C assay market. According to the report published by the Centers for Disease Control and Prevention (CDC) in 2022, more than 1 in 7 U.S. adults, about 14% or an estimated 37 million people are affected by CKD. Thus, as the incidence of chronic kidney diseases increases globally the demand for effective diagnostic solutions to measure the concentration of cystatin C, stimulating market growth.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Cystatin C Assay Market Size in 2023: | USD 269.6 Million |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 7.7% |
| 2032 Value Projection: | USD 522.6 Million |
| Historical Data for: | 2018 to 2023 |
| No. of Pages: | 195 |
| Tables, Charts & Figures: | 285 |
| Segments covered: | Product, Sample Type, Method, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Cystatin C Assay Market Scope
